Recap: Eton Pharmaceuticals Q2 Earnings



Eton Pharmaceuticals ETON reported its Q2 earnings results on Thursday, August 11, 2022 at 04:05 PM.

Here’s what investors need to know about the announcement.


Eton Pharmaceuticals missed estimated earnings by 300.0%, reporting an EPS of $-0.06 versus an estimate of $0.03.

Revenue was up $4.29 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.13 which was followed by a 7.61% increase in the share price the next day.

Here’s a look at Eton Pharmaceuticals’s past performance:


Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.08   -0.13 -0.14
EPS Actual -0.21 0.04 -0.24 -0.10
Revenue Estimate 7.10M 12.52M 3.04M 3.81M
Revenue Actual 2.18M 6.09M 775K 3.07M

To track all earnings releases for Eton Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.


Image and article originally from Read the original article here.